- Home
- JQC vs IRMD Comparison
JQC vs IRMD Comparison
Compare JQC & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JQC
- IRMD
- Stock Information
- Founded
- JQC 2003
- IRMD 1992
- Country
- JQC United States
- IRMD United States
- Employees
- JQC N/A
- IRMD N/A
- Industry
- JQC Finance Companies
- IRMD Medical/Dental Instruments
- Sector
- JQC Finance
- IRMD Health Care
- Exchange
- JQC Nasdaq
- IRMD Nasdaq
- Market Cap
- JQC 752.6M
- IRMD 756.5M
- IPO Year
- JQC N/A
- IRMD 2014
- Fundamental
- Price
- JQC $5.51
- IRMD $69.93
- Analyst Decision
- JQC
- IRMD Strong Buy
- Analyst Count
- JQC 0
- IRMD 1
- Target Price
- JQC N/A
- IRMD $72.00
- AVG Volume (30 Days)
- JQC 714.6K
- IRMD 48.0K
- Earning Date
- JQC 01-01-0001
- IRMD 08-01-2025
- Dividend Yield
- JQC 11.13%
- IRMD 0.98%
- EPS Growth
- JQC N/A
- IRMD 10.28
- EPS
- JQC N/A
- IRMD 1.61
- Revenue
- JQC N/A
- IRMD $77,635,163.00
- Revenue This Year
- JQC N/A
- IRMD $10.62
- Revenue Next Year
- JQC N/A
- IRMD $9.69
- P/E Ratio
- JQC N/A
- IRMD $43.12
- Revenue Growth
- JQC N/A
- IRMD 11.73
- 52 Week Low
- JQC $4.82
- IRMD $43.17
- 52 Week High
- JQC $5.65
- IRMD $71.92
- Technical
- Relative Strength Index (RSI)
- JQC 59.67
- IRMD 74.02
- Support Level
- JQC $5.41
- IRMD $67.51
- Resistance Level
- JQC $5.55
- IRMD $71.92
- Average True Range (ATR)
- JQC 0.03
- IRMD 2.35
- MACD
- JQC -0.00
- IRMD 1.37
- Stochastic Oscillator
- JQC 56.67
- IRMD 88.19
About JQC Nuveen Credit Strategies Income Fund Shares of Beneficial Interest
Nuveen Credit Strategies Income Fund is a diversified closed-end management investment company. Its investment objective is to provide high current income and total return. The fund meets its investment objectives by investing its managed assets in senior secured and second lien loans, and its managed assets across the capital structure of companies (including equity securities) with a primary emphasis on high yield bonds, convertible securities and other forms of income-producing securities.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.